跳至主要内容
临床试验/CTRI/2021/04/032528
CTRI/2021/04/032528已完成3 期

Role of NK-1 receptor antagonist for prevention of chemotherapy induced nausea and vomiting in patients receiving highly emetogenic chemotherapy (HEC): An Investigator-initiated, Multicenter, Double blind, Randomized, Placebo controlled, Superiority trial

CI AIIMS0 个研究点目标入组 250 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
250

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • a. Diagnosis of malignancy
  • b. No prior chemotherapy and radiation therapy (RT)
  • c. Age of 18 years or more, up to 70 years
  • d. ECOG Performance status (0-2)
  • e. Complete hemogram (ANC >=1000/m3, TLC >=3000/m3, Platelets >= 1,00,000/m3), Creatinine (<= 2 mg/dl), SGOT / SGPT (<= 3 X ULN, Bilirubin <2.0 mg/dl)
  • f. First cycle of highly emetogenic chemotherapy defined as
  • 1. Cisplatin at dose >=70mg/m2 with or without other agents
  • 2. Single agent Anthracycline (Doxorubicin >= 60mg/m2, Epirubicin >= 90mg/m2)
  • 3. AC (Doxorubicin >= 60mg/m2, Epirubicin >= 90mg/m2 + Cyclophosphamide >=
  • 4. Dacarbazine based therapy (ABVD)
  • g. Willing to give written informed consent for the study participation
  • h. Able to read and write in English or Hindi

排除标准

  • a. Patient receiving concurrent quinolone, amifostine, warfarin, OCP, psychiatric drugs, Benzodiazepines, Anti-convulsant drugs, strong or moderate CYP3A4 inhibitors (diltiazem, Ketoconazole), strong CYP3A4 inducers (rifampicin), pimozide, cisapride, terfenadine, astemizole, CYP1A2 inhibitors (ciprofloxacin, fluvoxamine)
  • b. History of chronic alcoholism
  • c. Hypersensitivity to any of the drugs used in the study {Olanzapine, NK-1 antagonist (Fosaprepitant), 5-HT3 antagonist â?? Ondansetron}
  • d. On systemic steroids, active smoker
  • e. History of any uncontrolled systemic disease including hypertension, thyroid, CNS, renal, CHF and MI in last 6 months and requiring hemodialysis, psychiatric disorder
  • f. Symptomatic Brain metastasis / Carcinomatous Meningitis
  • g. History of nausea and vomiting in 24 hours prior to first dose of chemotherapy
  • i. Use of anti-emetic drugs (5-HT3 Antagonist) in last 48 hours
  • j. Ascites requiring therapeutic paracentesis in last 2 weeks, Intestinal obstruction
  • k. Started on opioids in last 48 hours
  • l. Female who are pregnant, lactating
  • m. Diabetic patient on oral hypoglycemic drugs or Insulin

研究者

发起方
CI AIIMS

相似试验